In a welcome move, Enact Holdings saw its Relative Strength Rating rise from 67 to 74 on Friday.
When To Sell Stocks To Lock In Profits And Minimize Losses
IBD's unique RS Rating measures technical performance by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.
History shows that the best-performing stocks tend to have an RS Rating of above 80 in the early stages of their moves. See if Enact Holdings can continue to rebound and hit that benchmark.
Enact Holdings is working on a flat base with a 37.56 buy point. See if it can clear the breakout price in heavy volume.
Earnings growth dropped in the most recent quarter from 11% to 6%. But revenue moved higher, from 2% to 5%.
The company earns the No. 5 rank among its peers in the Finance-Mortgage & Related Services industry group. NMI Holdings is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
